These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 9780247

  • 1. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
    Orendi JM, Bloem AC, Borleffs JC, Wijnholds FJ, de Vos NM, Nottet HS, Visser MR, Snippe H, Verhoef J, Boucher CA.
    J Infect Dis; 1998 Nov; 178(5):1279-87. PubMed ID: 9780247
    [Abstract] [Full Text] [Related]

  • 2. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
    Cohen Stuart JW, Hazebergh MD, Hamann D, Otto SA, Borleffs JC, Miedema F, Boucher CA, de Boer RJ.
    J Acquir Immune Defic Syndr; 2000 Nov 01; 25(3):203-11. PubMed ID: 11115950
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR, Zaunders JJ, Cunningham P, Cooper DA.
    AIDS Res Hum Retroviruses; 1999 Jul 20; 15(11):963-72. PubMed ID: 10445808
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG, Lederman MM, Madero JS, Medvik K, Asaad R, Pacheko C, Carranza C, Valdez H.
    J Acquir Immune Defic Syndr; 2002 May 01; 30(1):33-40. PubMed ID: 12048361
    [Abstract] [Full Text] [Related]

  • 8. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct 01; 16(2):83-92. PubMed ID: 9358102
    [Abstract] [Full Text] [Related]

  • 9. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency.
    Liu Z, Cumberland WG, Hultin LE, Kaplan AH, Detels R, Giorgi JV.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug 01; 18(4):332-40. PubMed ID: 9704938
    [Abstract] [Full Text] [Related]

  • 10. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
    Resino S, Navarro J, Bellón JM, Gurbindo D, León JA, Muñoz-Fernández MA.
    Clin Exp Immunol; 2001 Aug 01; 125(2):266-73. PubMed ID: 11529919
    [Abstract] [Full Text] [Related]

  • 11. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S, Jouen-Beades F, Gilbert D, Borsa-Lebas F, Michel Y, Humbert G, Tron F.
    Clin Immunol Immunopathol; 1995 Oct 01; 77(1):33-41. PubMed ID: 7554481
    [Abstract] [Full Text] [Related]

  • 12. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR, Cone RW, Huber W, Battegay M, Vernazza PL, Weber R, Grob PJ, Opravil M.
    AIDS; 1998 Nov 12; 12(16):2115-23. PubMed ID: 9833852
    [Abstract] [Full Text] [Related]

  • 13. 'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.
    Lederman MM, Kalish LA, Asmuth D, Fiebig E, Mileno M, Busch MP.
    AIDS; 2000 May 26; 14(8):951-8. PubMed ID: 10853976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O, Holub M, Spála J, Kalanin J, Stanková M.
    Acta Virol; 2003 May 26; 47(2):121-4. PubMed ID: 14524479
    [Abstract] [Full Text] [Related]

  • 17. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL.
    Clin Exp Immunol; 1994 Mar 26; 95(3):436-41. PubMed ID: 7907956
    [Abstract] [Full Text] [Related]

  • 18. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity.
    Ferbas J, Kaplan AH, Hausner MA, Hultin LE, Matud JL, Liu Z, Panicali DL, Nerng-Ho H, Detels R, Giorgi JV.
    J Infect Dis; 1995 Aug 26; 172(2):329-39. PubMed ID: 7622874
    [Abstract] [Full Text] [Related]

  • 19. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.
    Bürgisser P, Hammann C, Kaufmann D, Battegay M, Rutschmann OT.
    Clin Exp Immunol; 1999 Mar 26; 115(3):458-63. PubMed ID: 10193418
    [Abstract] [Full Text] [Related]

  • 20. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
    Navarro J, Resino S, Bellón JM, Abad ML, Gurbindo D, Fernández-Cruz E, Muñóz-Fernández MA.
    AIDS Res Hum Retroviruses; 2001 Apr 10; 17(6):525-32. PubMed ID: 11350666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.